{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:40:47Z","timestamp":1773679247635,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.gyobfe.2015.09.009","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T07:37:18Z","timestamp":1446622638000},"page":"740-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Contraception et ob\u00e9sit\u00e9"],"prefix":"10.1016","volume":"43","author":[{"given":"M.","family":"Lobert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pigeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gronier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Catteau-Jonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.beem.2012.09.001","article-title":"Obesity and oral contraceptives: a clinician's guide","volume":"27","author":"Shaw","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.gyobfe.2015.09.009_bib0280","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/AOG.0b013e3181ac0544","article-title":"ACOG practice bulletin no.\u00a0105: bariatric surgery and pregnancy","volume":"113","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gyobfe.2015.09.009_bib0285","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/humrep\/deu006","article-title":"Effects of paternal and maternal lifestyle factors on pregnancy complications and perinatal outcome. A population-based birth-cohort study: the GECKO Drenthe cohort","volume":"29","author":"Mutsaerts","year":"2014","journal-title":"Hum Reprod"},{"issue":"jun15\u00a01","key":"10.1016\/j.gyobfe.2015.09.009_bib0290","doi-asserted-by":"crossref","first-page":"c2573","DOI":"10.1136\/bmj.c2573","article-title":"Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours","volume":"340","author":"Bajos","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.gyobfe.2015.09.009_bib0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamainternmed.2013.10522","article-title":"Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome","volume":"174","author":"Thomsen","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.gyobfe.2015.09.009_bib0310","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2012.11.003","article-title":"Hormonal contraceptives and arterial disease: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gyobfe.2015.09.009_bib0320","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.gyobfe.2014.01.024","article-title":"Cardiovascular risks of combined oral contraceptives\u00a0\u2013\u00a0beyond the French controversy","volume":"42","author":"Gronier-Gouvernel","year":"2014","journal-title":"Gynecol Obstet Fertil"},{"issue":"24","key":"10.1016\/j.gyobfe.2015.09.009_bib0325","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gyobfe.2015.09.009_bib0330","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ando.2012.09.001","article-title":"Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology","volume":"73","author":"Gourdy","year":"2012","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0335","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0340","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u20132010","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gyobfe.2015.09.009_bib0350","first-page":"569","article-title":"Myocardial infarction and oral contraceptives","volume":"192","author":"Bounhoure","year":"2008","journal-title":"Bull Acad Natl Med"},{"issue":"5","key":"10.1016\/j.gyobfe.2015.09.009_bib0355","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.contraception.2008.11.017","article-title":"Obesity and oral contraceptive pill failure","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gyobfe.2015.09.009_bib0360","first-page":"453","article-title":"Obesity and hormonal contraceptive efficacy","volume":"9","author":"Robinson","year":"2013","journal-title":"Womens Health"},{"issue":"2","key":"10.1016\/j.gyobfe.2015.09.009_bib0365","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic\u2013pituitary\u2013ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gyobfe.2015.09.009_bib0370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary\u2013ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gyobfe.2015.09.009_bib0375","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2012.12.001","article-title":"Contraceptive vaginal ring effectiveness is maintained during 6weeks of use: a prospective study of normal BMI and obese women","volume":"87","author":"Dragoman","year":"2013","journal-title":"Contraception"},{"issue":"2\u00a0Suppl.\u00a02","key":"10.1016\/j.gyobfe.2015.09.009_bib0380","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.gyobfe.2015.09.009_bib0385","doi-asserted-by":"crossref","first-page":"263e1","DOI":"10.1016\/j.ajog.2009.03.017","article-title":"Oral contraceptive effectiveness according to body mass index, weight, age, and other factors","volume":"201","author":"Dinger","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gyobfe.2015.09.009_bib0390","first-page":"849","article-title":"Contraception","volume":"61","author":"Gronier","year":"2011","journal-title":"Rev Prat"},{"issue":"5","key":"10.1016\/j.gyobfe.2015.09.009_bib0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/1745-7599.12011","article-title":"Contraception and the obese woman","volume":"25","author":"Reifsnider","year":"2013","journal-title":"J Am Assoc Nurse Pract"},{"issue":"2","key":"10.1016\/j.gyobfe.2015.09.009_bib0400","doi-asserted-by":"crossref","first-page":"110e1","DOI":"10.1016\/j.ajog.2012.05.002","article-title":"Pharmacokinetics of the etonogestrel contraceptive implant in obese women","volume":"207","author":"Mornar","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gyobfe.2015.09.009_bib0405","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.contraception.2004.10.005","article-title":"Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia","volume":"71","author":"Harrison-Woolrych","year":"2005","journal-title":"Contraception"},{"issue":"6\u00a0Suppl.","key":"10.1016\/j.gyobfe.2015.09.009_bib0410","doi-asserted-by":"crossref","first-page":"s85","DOI":"10.1016\/S0010-7824(98)00120-6","article-title":"Pharmacokinetics of implanon. An integrated analysis","volume":"58","author":"Huber","year":"1998","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0420","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"4","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gyobfe.2015.09.009_bib0425","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"Van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0430","series-title":"Medical eligibility criteria for contraceptive use: a WHO Family Planning Cornerstone [Internet]","author":"WHO","year":"2010"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0435","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.contraception.2011.04.016","article-title":"Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use","volume":"85","author":"Segall-Gutierrez","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gyobfe.2015.09.009_bib0440","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2009.07.008","article-title":"Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive","volume":"81","author":"Pantoja","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gyobfe.2015.09.009_bib0445","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2010.01.021","article-title":"Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously","volume":"81","author":"Segall-Gutierrez","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0450","first-page":"45","article-title":"Progestogen contraception using chlormadinone acetate in women presenting high vascular risk (A gynecoendocrine, metabolic and vascular study)","volume":"15","author":"Pelissier","year":"1987","journal-title":"Contracept Fertil Sex"},{"issue":"19","key":"10.1016\/j.gyobfe.2015.09.009_bib0455","first-page":"2431","article-title":"Contraceptions in women with contra-indication to estrogen-progestins","volume":"45","author":"Gompel","year":"1995","journal-title":"Rev Prat"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.gyobfe.2015.09.009_bib0465","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0470","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gyobfe.2015.09.009_bib0475","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gyobfe.2015.09.009_bib0480","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"issue":"18","key":"10.1016\/j.gyobfe.2015.09.009_bib0485","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0490","series-title":"Syndrome des ovaires polymicrokystiques","first-page":"1","author":"Robin","year":"2007"},{"issue":"76","key":"10.1016\/j.gyobfe.2015.09.009_bib0495","first-page":"215","article-title":"Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer","volume":"14","author":"Carlson","year":"2012","journal-title":"Discov Med"},{"issue":"4","key":"10.1016\/j.gyobfe.2015.09.009_bib0500","first-page":"242","article-title":"Quid de la contraception chez la femme ob\u00e8se et super ob\u00e8se en 2011\u00a0?","volume":"6","author":"Berdah","year":"2011","journal-title":"Obesite"},{"issue":"4","key":"10.1016\/j.gyobfe.2015.09.009_bib0505","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gyobfe.2015.09.009_bib0510","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.contraception.2012.05.012","article-title":"Results from pooled Phase III studies of ulipristal acetate for emergency contraception","volume":"86","author":"Moreau","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0515","series-title":"Recommandations HAS. Chirurgie de l\u2019ob\u00e9sit\u00e9 chez l\u2019adulte","year":"2009"},{"issue":"11","key":"10.1016\/j.gyobfe.2015.09.009_bib0520","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1381\/096089206778870148","article-title":"The impact of bariatric surgery on menstrual patterns","volume":"16","author":"Teitelman","year":"2006","journal-title":"Obes Surg"},{"issue":"2","key":"10.1016\/j.gyobfe.2015.09.009_bib0525","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000100067","article-title":"Challenging oral contraception after weight loss by bariatric surgery","volume":"64","author":"Merhi","year":"2007","journal-title":"Gynecol Obstet Invest"},{"issue":"6\u00a0Pt\u00a02","key":"10.1016\/j.gyobfe.2015.09.009_bib0530","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/0002-9378(90)90562-L","article-title":"Gastrointestinal disease and oral contraception","volume":"163","author":"Hanker","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gyobfe.2015.09.009_bib0535","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.contraception.2010.02.008","article-title":"Contraceptive use among women with a history of bariatric surgery: a systematic review","volume":"82","author":"Paulen","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2015.09.009_bib0270","series-title":"Recommandations HAS. Contraception chez la femme \u00e0 risque cardio-vasculaire","year":"2013"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958915002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958915002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T18:48:30Z","timestamp":1692125310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958915002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1297958915002684"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2015.09.009","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception et ob\u00e9sit\u00e9","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gyobfe.2015.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}